Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	65.33	72.9	76.68	108.91	77.83	63.56
Cash & Short-Term Investments	65.33	72.9	76.68	108.91	77.83	63.56
Cash Growth	-22.29%	-4.92%	-29.60%	39.93%	22.45%	586.84%
Prepaid Expenses	1.13	1.6	1.59	1.64	1.48	1.32
Restricted Cash	-	-	-	0.4	0.39	0.05
Other Current Assets	-	-	-	-	0.05	-
Total Current Assets	66.46	74.51	78.26	110.94	79.75	64.93
Property, Plant & Equipment	1.86	2.07	2.87	2.95	0.64	1.03
Other Long-Term Assets	0.33	0.32	0.31	0.3	-	0.44
Total Assets	68.65	76.9	81.45	114.19	80.39	66.4
Accounts Payable	6.52	7.57	7.95	10.13	5.54	4.34
Current Portion of Leases	0.59	0.58	0.54	0.5	0.31	0.43
Current Unearned Revenue	-	-	-	-	1	-
Total Current Liabilities	7.11	8.15	8.49	10.63	6.84	4.77
Long-Term Leases	0.84	0.99	1.57	2.08	0	0.31
Long-Term Unearned Revenue	35	35	35	35	-	-
Total Liabilities	42.95	44.14	45.07	47.71	6.84	5.08
Common Stock	0.03	0.03	0.03	0.03	0.02	0.02
Additional Paid-In Capital	417.43	408.55	373.93	355.22	329.27	292.28
Retained Earnings	-391.76	-375.83	-337.58	-288.77	-255.75	-230.97
Shareholders' Equity	25.69	32.76	36.38	66.48	73.55	61.32
Total Liabilities & Equity	68.65	76.9	81.45	114.19	80.39	66.4
Total Debt	1.43	1.57	2.11	2.58	0.31	0.74
Net Cash (Debt)	63.89	71.33	74.56	106.33	77.52	62.82
Net Cash Growth	-22.15%	-4.34%	-29.87%	37.16%	23.39%	702.73%
Net Cash Per Share	2.07	2.37	2.80	4.40	3.77	5.18
Filing Date Shares Outstanding	31.2	31.2	29.4	25.73	22.14	19.25
Total Common Shares Outstanding	31.2	31.2	27.63	25.67	22.14	17.53
Working Capital	59.35	66.36	69.77	100.31	72.91	60.16
Book Value Per Share	0.82	1.05	1.32	2.59	3.32	3.50
Tangible Book Value	25.69	32.76	36.38	66.48	73.55	61.32
Tangible Book Value Per Share	0.82	1.05	1.32	2.59	3.32	3.50
Machinery	-	1.26	1.24	1.09	0.68	0.6

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q